Nobel Biocare (NVST): Accounting Value per Share

NVST (Envista Holdings Corporation) - company brandmark

Envista Holdings (NVST) operates a global business selling dental equipment, although international conflicts and export restrictions may hinder overseas growth. This price action trend, shown below, is based on the 19.13 metric. The brand's products are considered a global benchmark, although they are currently undergoing a restructuring phase. Service stability in clinics and the production of certain devices are ensured through the engagement of external contractors.

NVST Envista Holdings Corporation Accounting Value per Share (07/04/2022 - 10/29/2026)

Financial and market metric breakdowns for envistaco.com (NVST)

- current quotes and average value forecast:
Price Chart Envista Holdings Corp|NVST - Analyst Median Target
- stock exchange capitalization data:
Market Valuation Envista Holdings|NVST - Aggregate Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Envista|NVST - Company Net Assets|Market Capitalization to Book Value Ratio envistaco.com|NVST - Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Envista Holdings|NVST - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Envista|NVST - Company Total Debt Obligations|Debts to Book Capitalization Envista Holdings|NVST - Company Long-Term Liabilities|Company Short-Term Debts Envista|Quick Liquidity envistaco.com
- earnings and multiples data:
NVST - Company Net Income
Fundamental company analysis:Envista Holdings Corp (NVST)
Manufactured products of envistaco.com

The scale of Envista Holdings (NVST) in the dental sector is reflected in the book value per share data. This metric determines the portion of net assets attributable to a single security, calculated as the difference between total assets and liabilities divided by the number of shares. Stable capital supports the brand's pricing power despite intense competitive pressure. Investors utilize this indicator to assess the intrinsic value of the business.

Competitor analysis

ISRG - Net Assets per Single Share|Net Assets per Share Danaher Corporation Inc. DHR|BDX (Becton Dickinson & Co) - Accounting Value per Share|STE: Book Price of a Share|Net Assets per Single Share West Pharmaceutical Services, Inc.|Accounting Value per Share Baxter International Inc. (BAX)|Book Value per Share MASI|STVN - Net Asset Value per Share|Book Value per Share TFX (Teleflex Incorporated)|MMSI: Equity per Share|ICU Medical - Book Value per Share|Net Assets per Share Dentsply Sirona Inc XRAY|LMAT: Book Value per Share|Accounting Value per Share AtriCure Medical|STAA (STAAR Surgical Company) - Book Value per Share|Book Value per Share Niagen|Net Assets per Single Share ZimVie (ZIMV)|Net Assets per Single Share ANGO (AngioDynamics Inc)|Cerus Corp - Accounting Value per Share|Accounting Value of a Share TKNO|Monogram Technologies - Book Value per Share|Net Assets per Share Sharps Technology, Inc. STSS|infusystem.com (INFU) - Net Assets per Single Share|Equity per Share UTMD|Net Assets per Single Share KORU Medical Systems, Inc.|Nyxoah S.A (NYXH) - Net Assets per Share|Accounting Value per Share MBOT (Microbot Medical Inc.)|Book Price of a Share PDEX|Net Assets per Single Share Zentek ZTEK|Accounting Value of a Share ELUT|MLSS: Accounting Value per Share|NXGL - Book Value per Share|retractable.com (RVP) - Net Assets per Single Share|Accounting Value per Share harvardbioscience.com|FEMY (Femasys) - Book Value per Share|Net Asset Value per Share Meihua Medical MHUA|Net Assets per Single Share Predictive Oncology (POAI)|callanjmb.com - Equity per Share|Atrion Corporation - Accounting Value per Share|Book Price of a Share NURO (neurometrix.com)